摘要: The advent of antiretroviral therapy (ART) for treatment HIV has significantly delayed HIV-related disease progression, allowing those infected to live longer without opportunistic infections. To some extent, become a chronic requiring long-term with multidrug regimens. A probability model the survival benefit AIDS in USA demonstrated that projected perperson after diagnosis increased 13.3 years from 19 months no available 14.9 2003 [1]. However, risks associated ART pose challenges patient care.
springer.com
sci-hub.st 参考文章(79)
J. A. Rump, H. Klinker, Sandra Brück, M. Hartmann, D. Petzold, M. Procaccianti, S. Witte, D. Schuster, J. Brust, F. Mosthaf, Hepatotoxicity in patients prescribed efavirenz or nevirapine. European Journal of Medical Research. ,vol. 13, pp. 343- 348 ,(2008)
Belitsos Pc, Chaisson Re, Fortgang Is, Moore Rd, Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. The American Journal of Gastroenterology. ,vol. 90, pp. 1433- 1436 ,(1995)
Thomas A. Grubert, Udo Jeschke, Ioannis Mylonas, Dirk Lebrecht, Bernd P. Kost, Bernhard Setzer, Andrea Gingelmaier, Klaus Friese, Ulrich A. Walker, Josef Mueller-Hoecker, Stephan Hiedl, Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Antiviral Therapy. ,vol. 14, pp. 331- 338 ,(2009)
Chin-Ho Chen, Yung-Chi Cheng, M. Vazquez-Padua, Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Molecular Pharmacology. ,vol. 39, pp. 625- 628 ,(1991)
Didier Neau, Maria Winnock, Laurent Cast??ra, Brigitte Le Bail, Marc-Arthur Loko, Laurent G??raut, Michel Dupon, Jean-Marie Ragnaud, Denis Lacoste, Marie-Edith Lafon, Paulette Bioulac-Sage, Fran??ois Dabis, Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort. Journal of Acquired Immune Deficiency Syndromes. ,vol. 45, pp. 168- 173 ,(2007) , 10.1097/QAI.0B013E318042E1DB
Richard M. Green, Steven Flamm, AGA technical review on the evaluation of liver chemistry tests Gastroenterology. ,vol. 123, pp. 1367- 1384 ,(2002) , 10.1053/GAST.2002.36061
Nancy Crum-Cianflone, Angelica Dilay, Gary Collins, Dean Asher, Richard Campin, Sheila Medina, Zach Goodman, Robin Parker, Alan Lifson, Thomas Capozza, Mary Bavaro, Braden Hale, Charles Hames, Nonalcoholic fatty liver disease among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes. ,vol. 50, pp. 464- 473 ,(2009) , 10.1097/QAI.0B013E318198A88A
Tim O. Lankisch, Ulrike Moebius, Michael Wehmeier, Georg Behrens, Michael P. Manns, Reinhold E. Schmidt, Christian P. Strassburg, Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype Hepatology. ,vol. 44, pp. 1324- 1332 ,(2006) , 10.1002/HEP.21361
Jason T Blackard, Minhee Kang, J Benjamin St Clair, Wenyu Lin, Yoshitaka Kamegaya, Kenneth E Sherman, Margaret James Koziel, Marion G Peters, Janet Andersen, Raymond T Chung, Aids Clinical Trials Group A5071 Study Team, None, Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon and Cytokine Research. ,vol. 27, pp. 263- 269 ,(2007) , 10.1089/JIR.2006.0147
Hyman J. Zimmerman, Drug-induced liver disease. Drugs. ,vol. 16, pp. 25- 45 ,(1978) , 10.2165/00003495-197816010-00002